These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 17475504)

  • 1. Therapeutic modulation of the nitric oxide: all ace inhibitors are not equivalent.
    Comini L; Bachetti T; Cargnoni A; Bastianon D; Gitti GL; Ceconi C; Ferrari R
    Pharmacol Res; 2007 Jul; 56(1):42-8. PubMed ID: 17475504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ace-inhibition with quinapril modulates the nitric oxide pathway in normotensive rats.
    Bachetti T; Comini L; Pasini E; Cargnoni A; Curello S; Ferrari R
    J Mol Cell Cardiol; 2001 Mar; 33(3):395-403. PubMed ID: 11181009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies.
    Ceconi C; Francolini G; Bastianon D; Gitti GL; Comini L; Ferrari R
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):423-9. PubMed ID: 18004652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of bradykinin and eNOS in the anti-ischaemic effect of trandolapril.
    Cargnoni A; Comini L; Bernocchi P; Bachetti T; Ceconi C; Curello S; Ferrari R
    Br J Pharmacol; 2001 May; 133(1):145-53. PubMed ID: 11325804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.
    Dinicolantonio JJ; Lavie CJ; O'Keefe JH
    Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compared properties of trandolapril, enalapril, and their diacid metabolites.
    Chevillard C; Jouquey S; Bree F; Mathieu MN; Stepniewski JP; Tillement JP; Hamon G; Corvol P
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S11-5. PubMed ID: 7527095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
    Gao L; Yu DM
    Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of high through-to-peak ratio of perindopril in SHR.
    Moriyama S; Ishigai Y; Mori T; Fukuzawa A; Shibano T
    Clin Exp Hypertens; 1999 Oct; 21(7):1223-38. PubMed ID: 10513838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of correlation of hypotensive effects with prevention of cardiac hypertrophy by perindopril after ligation of rat coronary artery.
    Chiba K; Moriyama S; Ishigai Y; Fukuzawa A; Irie K; Shibano T
    Br J Pharmacol; 1994 Jul; 112(3):837-42. PubMed ID: 7921610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perindopril alters vascular angiotensin-converting enzyme, AT(1) receptor, and nitric oxide synthase expression in patients with coronary heart disease.
    Zhuo JL; Mendelsohn FA; Ohishi M
    Hypertension; 2002 Feb; 39(2 Pt 2):634-8. PubMed ID: 11882622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy.
    Benigni A; Zoja C; Zatelli C; Corna D; Longaretti L; Rottoli D; Maggioni P; Todeschini M; Noris M; Remuzzi G
    Kidney Int; 2004 Nov; 66(5):1959-65. PubMed ID: 15496167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term low-dose angiotensin converting enzyme inhibitor treatment increases vascular cyclic guanosine 3',5'-monophosphate.
    Gohlke P; Lamberty V; Kuwer I; Bartenbach S; Schnell A; Linz W; Schölkens BA; Wiemer G; Unger T
    Hypertension; 1993 Nov; 22(5):682-7. PubMed ID: 8225528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
    Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
    Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfhydryl angiotensin-converting enzyme inhibition induces sustained reduction of systemic oxidative stress and improves the nitric oxide pathway in patients with essential hypertension.
    Napoli C; Sica V; de Nigris F; Pignalosa O; Condorelli M; Ignarro LJ; Liguori A
    Am Heart J; 2004 Jul; 148(1):e5. PubMed ID: 15215814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril increases the local extravasation of macromolecules and nitric oxide synthase in pancreas of the fructose-fed insulin-resistant rat model.
    Bouffard L; Papirakis ME; Maheux P
    Pancreas; 2006 Nov; 33(4):418-24. PubMed ID: 17079949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
    Chen SX; Song T; Zhou SH; Liu YH; Wu SJ; Liu LY
    Eur J Pharmacol; 2008 Apr; 584(2-3):368-75. PubMed ID: 18334254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats.
    Wojewódzka-Zelezniakowicz M; Chabielska E; Mogielnicki A; Kramkowski K; Karp A; Opadczuk A; Domaniewski T; Malinowska-Zaprzałka M; Buczko W
    J Physiol Pharmacol; 2006 Jun; 57(2):231-45. PubMed ID: 16845228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-lasting ex vivo inhibition by perindopril of rat vascular response to angiotensin I.
    Ishigai Y; Fukuzawa A; Chiba K; Irie K; Shibano T
    Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):633-8. PubMed ID: 7746024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.